Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About

EVER/BODY LAUNCHING AFTER RAISING $17 MILLION

Published October 4, 2019
Published October 4, 2019
Ever/Body

Ever/Body is launching after raising $17 million in funding, including a Series A round of financing led by Acme Capital.

WHO: Ever/Body is a provider of beauty treatments intended to demystify cosmetic dermatology. The company offers injectable medically tested cosmetic treatments and high-tech facials along with non-surgical solutions, providing clients with optimal results by reducing wrinkles to offer a younger and rejuvenated look. Co-founder and Chief Executive Officer, Kate Twist, was the global marketing and digital executive at Clinique and Xcel Brands and her cofounders have similarly impressive backgrounds: COO, Maggie Lu, last held a role as executive of strategy at Peloton, and CTO, Karen Castelletti, spent five years at Google as a software engineer.

IN THEIR OWN WORDS: “We did tons of consumer research, following this hunch we had, [with the goal of] demystifying this category that has been opaque and confusing,” Twist co-founder and Chief Executive Officer Kate Twist said to WWD.

“They want it faster, more intuitive and personalized,” Twist continued. Plus, Ever/Body is “more convenient and relaxing than a doctor’s office…[it] exists and fits into people’s lives in a more modern way.”

DETAILS:

  • Ever/Body raised $17 million in funding, including a Series A round of financing led by Acme Capital with additional funding from Tiger Global Management, Declaration Partners, and Redesign Health. Strategic investors include Warby Parker founders Neil Blumenthal and Dave Gilboa, Rent the Runway and Jetblack founder Jenny Fleiss, Harry’s and Warby Parker cofounder Jeff Raider, and Allbirds founder Joey Zwillinger.
  • The business is built to scale. Instead of a traditional retail buildout, Ever/Body’s treatment rooms are built off-site as mobile “pods” and can be packed up and moved easily to a different location if needed.
×

2 Article(s) Remaining

Subscribe today for full access